Morgan Stanley (NYSE:MS) analyst Vincent Andrews maintained a Hold rating on Nutrien (NYSE:NTR) Ltd on Monday, setting a price target of $50, which is approximately 1.92% above the present share price of $49.06.
Andrews expects Nutrien Ltd to post earnings per share (EPS) of -$1.03 for the fourth quarter of 2020.
The current consensus among 8 TipRanks analysts is for a Moderate Buy rating of shares in Nutrien, with an average price target of $47.73.
The analysts price targets range from a high of $56 to a low of $32.13.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $4.21 billion and a net profit of $127 million. The company's market cap is $27.92 billion.
According to TipRanks.com, Morgan Stanley analyst Vincent Andrews is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 3.8% and a 69.23% success rate.
Nutrien Ltd. is a crop nutrient company, which produces and distributes potash, nitrogen and phosphate products for agricultural, industrial and feed manufacturers. The company was founded on June 2, 2017 and is headquartered in Saskatoon, Canada.